Fortis Capital Advisors, LLC Dexcom Inc Transaction History

Fortis Capital Advisors, LLC

  • $299 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$114.22 - $140.1 $612,333 - $751,076
5,361 New
5,361 $744 Million
Q2 2023

Aug 14, 2023
BUY
$112.47 - $130.98 $10,234 - $11,919
91 Added 5.51%
1,744 $224 Million
Q1 2023

May 15, 2023
SELL
$104.0 - $122.92 $2,600 - $3,073
-25 Reduced 1.49%
1,653 $192 Million
Q4 2022

Feb 14, 2023
BUY
$84.98 - $122.67 $142,596 - $205,840
1,678 New
1,678 $190 Million

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Fortis Capital Advisors, LLC Portfolio

Follow Fortis Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortis Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortis Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email